Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

Harris Associates Concentrated Strategy's investment thesis on Liberty Capital Corporation ($LBRDK) — Q4 2025 | Buyside Digest

All Pitches

View Letter Analysis

$LBRDKNASDAQLiberty Capital Corporation

BULL

Harris Associates Concentrated Strategy—LBRDK

Fund Letter

Q4 2025

Published December 31, 2025

View Fund Profile

$36.02USD

—

$36.02Pitched

-0.0% since pitch

Market CapN/A

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

In the fourth quarter of 2025, the Harris Oakmark U.S. Concentrated Strategy returned 8.36% net, significantly outperforming the Russell 1000 Value Index's return of 3.81%. Major contributors to...

— Tony Coniaris

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $LBRDK, and what else Harris Associates Concentrated Strategy is buying.

Other pitches on $LBRDK

Other investors who've written on Liberty Capital Corporation

No other institutional pitches found for this ticker yet.

View all $LBRDK pitches →